282541-70-2

Basic information

• Product Name: Carbamic acid, methyl[2-(4-nitrophenyl)ethyl]-, 1,1-dimethylethyl ester
• CAS NO: 282541-70-2
• Molecular Formula: C14H20N2O4
• Molecular Weight: 280.324
• Mol File: 282541-70-2.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: Carbamic acid, methyl[2-(4-nitrophenyl)ethyl]-, 1,1-dimethylethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, methyl[2-(4-nitrophenyl)ethyl]-, 1,1-dimethylethyl ester(282541-70-2)
• EPA Substance Registry System: Carbamic acid, methyl[2-(4-nitrophenyl)ethyl]-, 1,1-dimethylethyl ester(282541-70-2)

Safety Data

• Hazardous Substances Data: 282541-70-2(Hazardous Substances Data)

Upstream product

• 98245-61-5 N-methyl-2-(4-nitrophenyl)acetamide 
• 24424-99-5 di-tert-butyl dicarbonate 
• 85176-37-0 N-methyl-N-[2-(4-nitro-phenyl)-ethyl]-amine 
• 166943-39-1 N-methyl-2-(4-nitrophenyl)-ethylamine hydrochloride 

Downstream Products

• 144222-24-2 [2-(4-amino-phenyl)-ethyl]-methyl-carbamic acid tert-butyl ester 
• 1001014-11-4 C₂₈H₃₁N₅O₂ 

Relevant articles and documents

METHODS OF USING SEMI-SYNTHETIC GLYCOPEPTIDES AS ANTIBACTERIAL AGENTS

Methods of using semi-synthetic glycopeptides of formula I-XIV having antibacterial activity are described.

1H-IMIDAZO[4,5-C]QUINOLINE DERIVATIVES IN THE TREATMENT OF PROTEIN KINASE DEPENDENT DISEASES

The invention relates to the use of imidazoquinolines and salts thereof in the treatment of protein kinase diseases and for the manufacture of pharmaceutical preparations for the treatment of said diseases, imidazoquinolines for use in the treatment of protein kinase dependent diseases, a method of treatment against said diseases, comprising administering the imidazoquinolines to a warm-blooded animal, especially a human, pharmaceutical preparations comprising an imidazoquinoline, especially for the treatment of a protein kinase dependent disease, novel imidazoquinolines, and a process for the preparation of the novel imidazoquinolines.